What the 2025 EU GMP Revisions mean for digitalization and Artificial Intelligence
Is compliance blocking your digital transformation? Join this webinar to learn how to align compliance with 2025 EU GMP Revisions and unlock your digital transformation!
🎤 Featuring Andrés Gola, Senior Consultant at PBSV, expert in FDA-regulated environments, quality systems and GMP.
Are you leading digital transformation initiatives in Life Sciences?
AI is drastically reshaping our industry, defining how innovation moves forward. It then becomes critical to understand the 2025 draft revisions to EU GMP, Chapter 4, Annex 11, and Annex 22 inside out.
That’s why we’ve organized a webinar designed to help you align your compliance strategies with these revisions. You’ll gain practical insights on how to:
- Translate the new requirements in Chapter 4, Annex 11, and Annex 22 into actionable digital and operational priorities.
- Strengthen data governance and documentation to build AI-readiness and enable data-driven decision-making.
- Validate IT systems and AI tools so they remain traceable, compliant, and audit-ready.
- Foster collaboration between QA, IT, and suppliers to implement AI in a secure, compliant, and sustainable way.
You’ll hear from Andrés Gola, Senior Consultant at PBSV, who brings 15 years of experience in FDA-regulated environments, specializing in quality systems, GMP, and FDA inspections.
Angel Buendía, Scilife’s Knowledge Manager, will be moderating this online session.
📅 September 30th, 2025 | 11:00H (CEST)
This session holds the very key to future-proofing your digitalization and AI initiatives, and we’re handing it to you.